Palatin Technologies
PTN
#9873
Rank
A$53.99 M
Marketcap
A$30.47
Share price
-7.53%
Change (1 day)
2,300.38%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$7.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$8.84 Million. In 2024 the company made an earning of -A$38.21 Million, an increase over its 2023 earnings that were of -A$45.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.94 Million-79.24%
2024 -A$38.21 Million-16.9%
2023 -A$45.98 Million5.99%
2022 -A$43.39 Million-13.7%
2021 -A$50.27 Million33.25%
2020 -A$37.73 Million-172.11%
2019 A$52.31 M2352.33%
2018 A$2.13 M-94.13%
2017 A$36.34 M-154.92%
2016 -A$66.19 Million3.67%
2015 -A$63.85 Million878%
2014 -A$6.53 Million-72.64%
2013 -A$23.86 Million-33.11%
2012 -A$35.67 Million77.71%
2011 -A$20.08 Million
2003 -A$33.99 Million29.93%
2002 -A$26.16 Million36.18%
2001 -A$19.21 Million
1999 -A$15.95 Million6.04%
1998 -A$15.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.94 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$18.56 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$0.82 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$17.03 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$94.73 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$71.69 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$41.82 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$78.79 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA